To date, the relationship between Gaucher disease and α-synucleinopathies such as PD, DLBs, and MSA has been unraveled to some extent such that PD and LBDs patients with GBA1 mutations typically show an earlier onset of the diseases and more severe symptoms than control group [32]. This evidence concerns the gene GBA1 and Gaucher disease.